Biomedical, Clinical & Life Sciences

Institutionally Coordinated // Limit: 1
Please contact RDS for more information. 

This award recognizes an outstanding assistant-level faculty member who demonstrates leadership potential in addressing inequity in medical education and health care; demonstrates efforts in addressing educational, societal, and health care needs of racial and ethnic minorities in the United States; and is committed to a career in academic medicine.

The recipient receives a $25,000 grant to support a project performed in the United States to support racial and ethnic minorities. Recipients are required to accept the award at Learn Serve Lead 2024: The AAMC Annual Meeting in Atlanta, GA.

A medical school may nominate one current faculty member per year for this award. A candidate must:

• Be a U.S. citizen or permanent resident.
• Hold the rank of full-time assistant professor in a LCME-accredited U.S. medical school department.
• Have held the assistant professor position appointment beginning no earlier than July 1, 2021.
• Have received only one appointment as assistant professor.
• Hold a MD, PhD, or have earned another doctoral degree.

No Applicants // Limit: 1 // Tickets Available: 1 

Only one application per institution (normally identified by having a unique UEI number) is allowed.

This Notice of Funding Opportunity (NOFO) supports research to implement and evaluate strategies aligned with CDC’s What Works in Schools (WWIS) approach for successful implementation in local education agencies and schools serving rural or American Indian and/or Alaska Native (AI/AN) adolescents to address students’ health behaviors, experiences, and outcomes, particularly those related to sexual and reproductive health and mental and behavioral health, as well as suicidality, substance use, and experiences of violence. The purpose of the research is to build the evidence base for innovative, school-based or school-linked strategies that promote the health of youth across multiple health domains while also supporting translation and dissemination of the research findings. Strategies may include programs, policies, or practices that seek to improve sexual and reproductive health as well as improve mental and behavioral health in a manner that also addresses health equity among youth in local education agencies and schools serving rural or AI/AN adolescents. Additionally, strategies may also seek to reduce suicidality, substance use and experiences of violence among school-aged adolescents.

The estimated total funding (direct and indirect) for the first year (12-month budget period) will be $1,000,000.00 with individual awards of $500,000.00 each for two awards. The estimated total funding (direct and indirect) for the entire project period will be $5,000,000.00. The project period is anticipated to run from 09/29/2024 to 09/28/2029.

Limit: 1 // PI: N. Halvax ( Family & Community Medicine)

AHCCCS is investing funds from the American Rescue Plan (ARP) into an award program to strengthen Home and Community Based Services (HCBS) in the state. You can find more information on the ARP and Arizona’s spending plans on the AHCCCS ARP Allocations web page.

The ARP Program Awards are intended to enhance the health, safety, and member experience for individuals who receive HCBS. AHCCCS members who can directly benefit include Arizona Long Term Care System (ALTCS) and non-ALTCS members like:

• Individuals who are elderly,
• Individuals with disabilities,
• Individuals living with a Serious Mental Illness (SMI) designation, and
• Children with behavioral health needs.

Eligible HCBS providers can request between $10,000 and $1,000,000 for programmatic or infrastructure projects

 Limit: 1 // H. Ding (Translational Pharmacogenomics)

One nomination will be invited from each of the participating institutions.

The Pew Scholars Program in the Biomedical Sciences provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level. The current grant level is $300,000; $75,000 per year for a four-year period.

Candidates must hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.

Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Candidates must meet all of the following eligibility requirements:

• Hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
• As of Sept. 7, 2024, run an independent lab and hold a full-time appointment at the rank of assistant professor.
• Must not have been appointed as an assistant professor at any institution prior to June 12, 2020, whether or not such an appointment was on a tenure track. Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this four-year limit. Candidates who need an exception on the four-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
  • Please note that the eligibility criteria above have been temporarily expanded to account for COVID-related lab shutdowns. Please direct any questions to the program office at scholarsapp@pewtrusts.org.
• May apply to the program a maximum of two times. 
• If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
• May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.

No Applicants // Limit: 1 // Tickets Available: 1

Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

This notice of funding opportunity (NOFO) invites applications from clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN) and contribute to the network's capacity torespond to urgent public health needs. The National Institute on Drug Abuse (NIDA) intends to continue to develop and test interventions for addressing the wide spectrum of substance use problems via collaborative partnerships among NIDA, clinical research investigators, community representatives, healthcare providers, and healthcare institutions.  

This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material. Application budgets are limited to $500,000 per year in direct costs. Facilities and administrative costs requested by consortium participants are not included in the direct cost limitation.The maximum project period is seven years. 

No applicats  // Limit: 1 // Tickets Available: 1

DOL will consider only one application from each organization.

Under this Funding Opportunity Announcement (FOA), DOL will award grants through a competitive process to organizations providing pre-apprenticeship services that support education, occupational skills training, and employment services to opportunity youth, ages 16 to 24, while performing meaningful work and service to their communities. The YouthBuild program model prepares participants for quality jobs in a variety of careers, in diverse industry sectors, particularly in infrastructure sectors, and includes wrap-around services such as mentoring, trauma-informed care, personal counseling, transportation supports, and employment preparation - all key strategies for addressing violence in communities. YouthBuild applicants must include construction skills training and may include occupational skills training in other indemand industries. This expansion into additional in-demand industries is the Construction Plus component 

No applicants   // Limit: 1 // Tickets Available: 1 

Only one application per institution (normally identified by having a unique NIH Institutional Profile Number, IPF) is allowed.

The goal of the Medical Scientist Training Program (MSTP) is to develop a diverse pool of highly trained clinician-scientist leaders available to meet the Nation’s biomedical research needs. Specifically, this fundingopportunity announcement (FOA) provides support to eligible domestic institutions to develop and implement effective, evidence-informed approaches to integrated dual-degree training leading to the award of both clinical degrees, e.g., M.D., D.O., D.V.M., D.D.S., Pharm.D., and research doctorate degrees (Ph.D.). With the dual qualification of rigorous scientific research and clinical practice, graduates will be equipped with the skills to develop research programs that accelerate the translation of research advances to the understanding, detection, treatment and prevention of human disease, and to lead the advancement of biomedical research. Areas of particular importance to NIGMS are the iterative optimization of MSTP training efficacy and efficiency, fostering the persistence of MSTP alumni in research careers, and enhancing the diversity of the clinician-scientist workforce. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation.
 

No applicants // Limit: 1 // Tickets Available: 1

HRSA will only review the last validated application before the Grants.gov due date.

The Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) is accepting applications for the fiscal year (FY) 2024 Ryan White HIV/AIDS Program (RWHAP) Implementation for HIV Clinical QualityImprovement program. The purpose of this program is to provide RWHAP Part A through D recipients with training and technical assistance (T/TA) to implement quality improvement methodologies and concepts with an emphasis on skills development and implementing sustainable quality improvement activities for RWHAP Part A through D recipients with little or no experience in quality improvement. The activities outlined in this Notice of Funding Opportunity (NOFO) align with the Ryan White HIV/AIDS Program statute and HRSA HAB Clinical Quality Management (CQM) Policy Clarification Notice 15-02 (PCN 15-02). Specifically, PCN 15-02 clarifies that CQM programs consist of three components: infrastructure, performance measurement, and quality improvement. This cooperative agreement will address the quality improvement component. 

No applicants // Limit: 1 // Tickets Available: 1

Only one application per institution (normally identified by its UEI number) is allowed.

The purpose of this NOFO is to support comparative effectiveness trials to investigate the feasibility, effectiveness, and cost-effectiveness of telehealth-based interventions to detect and manage glaucoma among high-risk populations. This NOFO aims to support the study of replicable and scalable interventions that use real-world, payer-provider reimbursement structures within community-based, health care delivery settings in various regions of the United States. Outcomes should be relevant to clinical practice, public health, community implementation, and policy. This NOFO also supports the cost-effectiveness analyses of proposed interventions. The resulting data will assist policymakers, clinicians, and patients make informed decisions to reduce the burden of glaucoma and improve the quality of life for millions of people.

This NOFO will be accomplished through two components, Component A: Comparative effectiveness trials among high-risk populations within community-based settings, and Component B: a coordinating center to provide scientific and logistical support to Component A studies. 

Component A: Number of Awards: four (4); Estimated Funding: $2,750,000
Component B: Coordinating Center Number of Awards: One (1); Estimated Funding: $250,000

No Applicants // Limit: 1 // Tickets Available: 1

Only one application per institution (normally identified by having a unique entity identifier [UEI] number) is allowed. 

This Notice of Funding Opportunity (NOFO) is designed to understand the feasibility and acceptability of providing long-acting injectable antiretroviral therapy (LAI-ART) to incarcerated persons with HIV who are soon to be released from state prison facilities. The ultimate goal is to support the development and implementation of effective, sustainable, replicable LAI-ART programs. People with HIV living in prison facilities are often released to the community lacking support for ongoing HIV care. There is a paucity of programs for this population demonstrating effectiveness with retention in care and maintaining sustained HIV viral suppression after release. The use of LAI-ART prior to and at the time of release from prison may improve adherence to HIV treatment, retention in care, and maintenance of viral load suppression among persons reentering the community. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART and is aligned with the HIV National Strategic Plan (2022-2025) and the Ending the HIV Epidemic in the U.S. (EHE) initiative “Treat” Pillar.